For four decades, St. Lucia and the rest of the Organisation of Eastern Caribbean States (OECS) through the OECS Pharmaceutical Procurement Service (OECS-PPS), has quietly stood behind some of the region’s greatest public health successes. From medicine delivered to hospitals, emergency medical supplies dispatched following a disaster, and life-saving commodities made available during a disease outbreak, the work delivered by the OECS-PPS tells the story of an institution built on the idea that the Member States of the OECS are stronger when they work together.
As the OECS Commission commemorates the 40th Anniversary of the OECS-PPS under the theme “Honouring Our Legacy: Inspiring the Future,” the organization says “it celebrates far more than an institutional milestone. It celebrates four decades of visionary leadership, practical regional cooperation and a shared commitment by OECS Member States to improve the quality of life of their people through collective action.”
Established on 1 August 1986 through a United States Agency for International Development (USAID)-funded initiative, the OECS-PPS became a fully self-financing Unit of the OECS Commission in 1990. The initiative began with approximately 200 medicines with an annual procurement value of EC$2 million which has evolved into one of the Caribbean’s most respected regional health institutions. Today, the OECS Pharmaceutical Procurement Service procures approximately 1,100 medicines and essential health commodities, including pharmaceuticals, medical supplies, laboratory products, reproductive health commodities and radiological supplies, with an annual procurement portfolio approaching EC$30 million.
The organization is confident that, over the past forty years, the OECS-PPS has become one of the regions clearest demonstrations of regional integration in action. By pooling the pharmaceutical and health commodity requirements of participating Member States, the OECS-PPS’s mandate is to secure competitive international pricing, strengthened quality assurance, improved supply chain management and ensured more reliable access to safe, quality and affordable medicines across the Eastern Caribbean.
The OECS-PPS continues to generate significant economic benefits for participating Member States. Through pooled procurement and economies of scale, OECS Member States collectively realise an estimated EC $5 million in annual cost-savings, resources that can instead be reinvested into strengthening national health systems and improving healthcare delivery.
Beyond the financial savings, the OECS-PPS has helped harmonise the OECS Essential Medicines List (EML) and OECS Essential Diagnostics List (EDL), strengthen laboratory systems, improve prescribing practices, enhance pharmaceutical quality assurance through internationally accredited testing and post-market surveillance, and build technical capacity in procurement and supply chain management throughout the region.
The regional body believes that the OECS Pharmaceutical Procurement Service cannot be measured by procurement volumes or financial savings alone.
It highlights that over the past four decades, “the Service has evolved into a strategic pillar of regional health security, helping Member States prepare for and respond to some of the region’s most significant public health and humanitarian challenges.”
During the COVID-19 pandemic and subsequent disease outbreak preparedness efforts, it explains, “the OECS-PPS strengthened regional emergency supply chain capacity by supporting training, improving operational preparedness and enhancing systems for the rapid procurement and distribution of essential medical supplies. These efforts strengthened the region’s collective ability to respond to emerging public health threats while safeguarding continuity of care.”
Director General of the OECS Commission, Dr Didacus Jules, said the OECS-PPS exemplifies the OECS’ mission of delivering practical regional solutions that improve people’s lives. He stated:
“For forty years, the OECS Pharmaceutical Procurement Service has stood as one of the Organisation’s most compelling demonstrations of the power of regional integration. It represents what is possible when our Member States act collectively to achieve outcomes that would be difficult to realise individually. Beyond the millions of dollars in savings, the true measure of the OECS-PPS lies in the confidence it gives our citizens that safe, quality and affordable medicines can be procured through a trusted regional mechanism.
As we celebrate this important milestone, we honour the vision of those who established this programme, the dedication of the professionals who have sustained it, and the enduring commitment of our Member States to collective action. The OECS-PPS remains a flagship institution of our Organisation and an enduring symbol of the OECS Commission’s mission to improve the quality of life of every citizen through practical, innovative and sustainable regional solutions.”
As part of the anniversary observance, the OECS Pharmaceutical Procurement Service will host a staff consultation on 28 August 2026, bringing together present team members to reflect on the OECS-PPS’ remarkable journey, celebrate its achievements and help shape its next chapter of innovation and regional service.
40 YEARS AT A GLANCE
- Established in 1986.
- Became a fully self-financing OECS Commission unit in 1990.
- Product portfolio expanded from 200 to approximately 1,100 health commodities.
- Annual procurement portfolio increased from EC$2 million to nearly EC$30 million.
- Generates an estimated EC$5 million in annual cost-savings for Member States.
- Harmonised regional Essential Medicines and Essential Diagnostics Lists.
- Strengthened pharmaceutical quality assurance and laboratory systems.
- Built regional procurement and supply chain capacity.
- Enhanced emergency preparedness for disease outbreaks.
- Supported regional disaster response through the OECS–Direct Relief partnership.
- Continues to strengthen health security and improve access to essential medicines across the OECS.